Skip to main content

Table 5 Additional advice provided by pharmacists during consultations (count and %)

From: Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement

Advice provided

Original EpiPen

New-look EpiPen

Anapen

Total

P value*

 

(n = 87)

(n = 92)

(n = 87)

(n = 266)

 

Do you know what you reacted to?

66 (75.9)

67 (72.8)

45 (51.7)

178 (66.9)

0.001

Explain signs of anaphylaxisa

64 (73.6)

74 (80.4)

36 (41.4)

174 (65.4)

<0.001

Call ambulance after using epinephrine

53 (60.9)

60 (65.2)

46 (52.9)

159 (59.8)

0.23

Identify expiry date of researcher’s device

53 (60.9)

38 (41.3)

41 (47.1)

132 (49.6)

0.03

Are you seeing an allergy specialist?

6 (6.9)

16 (17.4)

30 (34.5)

52 (19.5)

<0.001

Conditions for device storage

20 (23)

16 (17.4)

15 (17.2)

51 (19.2)

0.49

Side effects of epinephrine

7 (8)

9 (9.8)

5 (5.7)

21 (7.9)

0.61

Do you have an anaphylaxis action plan?

4 (4.6)

10 (10.9)

1 (1.1)

15 (5.6)

0.02b

  1. *Pearson chi-squared p-value for comparison of advice provided across groups.
  2. aPharmacist explained the signs of severe allergic reaction as listed on the relevant ASCIA Action Plan for Anaphylaxis at the time of this research[30].
  3. bFisher’s exact test used.